These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38800769)

  • 1. Exploring Serum Vitamin D, Sex Hormones, and Lipid Profile Disparities in Women With and Without Polycystic Ovarian Syndrome: A Case-Control Study.
    Akinola LA; Inyangudo GN; Ottun AT; Olumodeji AM; Adewunmi AA; Olalere FH; Omololu OM; Ogungbemile BD
    Cureus; 2024 May; 16(5):e60975. PubMed ID: 38800769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
    Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
    Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of vit D and AMH and its correlation with polycystic ovarian parameters in obese and non-obese Egyptian women.
    Hegazy M; El-Mahdy HA; Elsayed TS; Elkhawaga SY; Elkady MA; Yehia AM; El-Husseiny AA; Shaban HM; Gomaa MH; Mokhtar MM
    Pathol Res Pract; 2023 Nov; 251():154872. PubMed ID: 37820441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
    Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
    Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
    Kumar AN; Naidu JN; Satyanarayana U; Ramalingam K; Anitha M
    Int J Fertil Steril; 2016; 10(1):22-8. PubMed ID: 27123196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Serum Anti-Mullerian Hormone with Clinical, Metabolic and Hormonal Parameters in Bangladeshi Women with Polycystic Ovary Syndrome: A Cross-sectional Study.
    Aalpona FZ; Ananya KF; Kamrul-Hasan AB
    Mymensingh Med J; 2023 Jul; 32(3):606-612. PubMed ID: 37391947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
    Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.
    Shah AK; Yadav BK; Suri A; Shah AK
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):357-361. PubMed ID: 35439403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.
    Chun S
    Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.